InsidersTradesSigma
Follow the Hepion Pharmaceuticals, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8m. The latest transaction was reported on 28 November 2023 (Acquisition). Among the most active insiders: Wijngaard Peter. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for liver diseases. It primarily concentrates on the research and development of innovative drugs.